Daclizumab Japanese PK Study
NCT01929746
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
56
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
BIOLOGICAL:
BIIB019 subcutaneous injection
Sponsor
Biogen
Collaborators
[object Object]